EpiPen (0.3 mg) auto-injector shortage in Canada
In plain language
This recall involves a reported shortage of EpiPen (0.3 mg) auto-injectors in Canada. Pfizer Canada is managing distribution due to potential temporary supply constraints. EpiPen Jr (0.15 mg) is not affected by this shortage.
What to do
- Talk to your pharmacist if you have questions or concerns.
- Visit drugshortagescanada.ca for more information.
- Contact Pfizer Canada if you have questions about EpiPen availability.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
EpiPen (0.3 mg) auto-injector
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
This recall involves a reported shortage of EpiPen (0.3 mg) auto-injectors in Canada. Pfizer Canada is managing distribution due to potential temporary supply constraints. EpiPen Jr (0.15 mg) is not affected by this shortage.
What should consumers do?
Talk to your pharmacist if you have questions or concerns. Visit drugshortagescanada.ca for more information. Contact Pfizer Canada if you have questions about EpiPen availability.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
A potential safety risk has been identified with this product. Stop using it immediately and follow the instructions in the official recall notice.
When was this product recalled?
This product was recalled on July 19, 2019.
Is the EpiPen brand affected by this recall?
Yes, EpiPen products are affected by this recall. This recall involves a reported shortage of EpiPen (0.3 mg) auto-injectors in Canada. Pfizer Canada is managing distribution due to potential temporary supply constraints. EpiPen Jr (0.15 mg) is not affected by this shortage.